Eurofins Scient (OTCMKTS:ERFSF) Receives Average Recommendation of “Hold” from Analysts

Shares of Eurofins Scient (OTCMKTS:ERFSF) have been assigned a consensus recommendation of “Hold” from the five brokerages that are covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company.

A number of analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. Finally, Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a research report on Monday.

Eurofins Scient Price Performance

Shares of ERFSF stock opened at $82.60 on Thursday. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. Eurofins Scient has a 12-month low of $48.55 and a 12-month high of $86.20. The stock’s 50-day moving average price is $76.19 and its 200-day moving average price is $74.68.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.